Li, H., Zhang, L., Ren, H., & Hu, P. (2018). Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B. Infect Drug Resist.
Stile di citazione ChicagoLi, Hu, Li Zhang, Hong Ren, e Peng Hu. "Higher Baseline Viral Diversity Correlates With Lower HBsAg Decline Following PEGylated Interferon-alpha Therapy in Patients With HBeAg-positive Chronic Hepatitis B." Infect Drug Resist 2018.
Citazione MLALi, Hu, Li Zhang, Hong Ren, e Peng Hu. "Higher Baseline Viral Diversity Correlates With Lower HBsAg Decline Following PEGylated Interferon-alpha Therapy in Patients With HBeAg-positive Chronic Hepatitis B." Infect Drug Resist 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.